| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois-Lausanne, Lausanne, Switzerland;
Pharma Research, Novartis, Basel, Switzerland;
Ludwig Institute for Cancer Research, Epalinges, Switzerland; and
§
Research Department, Kantonspital, Basel, Switzerland
Cellular responses to LPS, the major lipid component of the outer membrane of Gram-negative bacteria, are enhanced markedly by the LPS-binding protein (LBP), a plasma protein that transfers LPS to the cell surface CD14 present on cells of the myeloid lineage. LBP has been shown previously to potentiate the host response to LPS. However, experiments performed in mice with a disruption of the LBP gene have yielded discordant results. Whereas one study showed that LBP knockout mice were resistant to endotoxemia, another study did not confirm an important role for LBP in the response of mice challenged in vivo with low doses of LPS. Consequently, we generated rat mAbs to murine LBP to investigate further the contribution of LBP in experimental endotoxemia. Three classes of mAbs were obtained. Class 1 mAbs blocked the binding of LPS to LBP; class 2 mAbs blocked the binding of LPS/LBP complexes to CD14; class 3 mAbs bound LBP but did not suppress LBP activity. In vivo, class 1 and class 2 mAbs suppressed LPS-induced TNF production and protected mice from lethal endotoxemia. These results show that the neutralization of LBP accomplished by blocking either the binding of LPS to LBP or the binding of LPS/LBP complexes to CD14 protects the host from LPS-induced toxicity, confirming that LBP is a critical component of innate immunity.
This article has been cited by other articles:
|
|
 |
|
  B. Daubeuf, J. Mathison, S. Spiller, S. Hugues, S. Herren, W. Ferlin, M. Kosco-Vilbois, H. Wagner, C. J. Kirschning, R. Ulevitch, et al. TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock J. Immunol., November 1, 2007; 179(9): 6107 - 6114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lehnert, T. Uehara, B. U. Bradford, H. Lind, Z. Zhong, D. A. Brenner, I. Marzi, and J. J. Lemasters Lipopolysaccharide-binding protein modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G456 - G463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Akashi-Takamura, T. Furuta, K. Takahashi, N. Tanimura, Y. Kusumoto, T. Kobayashi, S.-i. Saitoh, Y. Adachi, T. Doi, and K. Miyake Agonistic Antibody to TLR4/MD-2 Protects Mice from Acute Lethal Hepatitis Induced by TNF-{alpha} J. Immunol., April 1, 2006; 176(7): 4244 - 4251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Branger, S. Florquin, S. Knapp, J. C. Leemans, J. M. Pater, P. Speelman, D. T. Golenbock, and T. van der Poll LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia Int. Immunol., November 1, 2004; 16(11): 1605 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lanza-Jacoby, S. Miller, S. Jacob, D. Heumann, A. G. Minchenko, and J. T. Flynn Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice Innate Immunity, December 1, 2003; 9(6): 341 - 347. [Abstract] [PDF]
|
|
|
|
|
|
D. Heumann, R. Lauener, and B. Ryffel The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds Innate Immunity, December 1, 2003; 9(6): 381 - 384. [Abstract] [PDF]
|
|
|
|
|
|
M. d. J. Arana, M. G. Vallespi, G. Chinea, G. V. Vallespi, I. Rodriguez-Alonso, H. E. Garay, W. A. Buurman, and O. Reyes Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction Innate Immunity, October 1, 2003; 9(5): 281 - 291. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Ohgami, I. B. Ilieva, K. Shiratori, E. Isogai, K. Yoshida, S. Kotake, T. Nishida, N. Mizuki, and S. Ohno Effect of Human Cationic Antimicrobial Protein 18 Peptide on Endotoxin-Induced Uveitis in Rats Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4412 - 4418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Nagaoka, S. Hirota, F. Niyonsaba, M. Hirata, Y. Adachi, H. Tamura, S. Tanaka, and D. Heumann Augmentation of the Lipopolysaccharide-Neutralizing Activities of Human Cathelicidin CAP18/LL-37-Derived Antimicrobial Peptides by Replacement with Hydrophobic and Cationic Amino Acid Residues Clin. Vaccine Immunol., September 1, 2002; 9(5): 972 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ishida, H. Kubo, S. Suzuki, T. Suzuki, S. Akashi, K. Inoue, S. Maeda, H. Kikuchi, H. Sasaki, and T. Kondo Hypoxia Diminishes Toll-Like Receptor 4 Expression Through Reactive Oxygen Species Generated by Mitochondria in Endothelial Cells J. Immunol., August 15, 2002; 169(4): 2069 - 2075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fierer, M. A. Swancutt, D. Heumann, and D. Golenbock The Role of Lipopolysaccharide Binding Protein in Resistance to Salmonella Infections in Mice J. Immunol., June 15, 2002; 168(12): 6396 - 6403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Uesugi, M. Froh, G. E. Arteel, B. U. Bradford, M. D. Wheeler, E. Gabele, F. Isayama, and R. G. Thurman Role of Lipopolysaccharide-Binding Protein in Early Alcohol-Induced Liver Injury in Mice J. Immunol., March 15, 2002; 168(6): 2963 - 2969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zweigner, H.-J. Gramm, O. C. Singer, K. Wegscheider, and R. R. Schumann High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes Blood, December 15, 2001; 98(13): 3800 - 3808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Heumann CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria Innate Immunity, December 1, 2001; 7(6): 439 - 441. [Abstract] [PDF]
|
|
|
|
|
|
I. Nagaoka, S. Hirota, F. Niyonsaba, M. Hirata, Y. Adachi, H. Tamura, and D. Heumann Cathelicidin Family of Antibacterial Peptides CAP18 and CAP11 Inhibit the Expression of TNF-{alpha} by Blocking the Binding of LPS to CD14+ Cells J. Immunol., September 15, 2001; 167(6): 3329 - 3338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Le Roy, F. Di Padova, Y. Adachi, M. P. Glauser, T. Calandra, and D. Heumann Critical Role of Lipopolysaccharide-Binding Protein and CD14 in Immune Responses against Gram-Negative Bacteria J. Immunol., September 1, 2001; 167(5): 2759 - 2765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Schrijver, M. van Meurs, M.-J. Melief, C. Wim Ang, D. Buljevac, R. Ravid, M. P. Hazenberg, and J. D. Laman Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis Brain, August 1, 2001; 124(8): 1544 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Heumann, Y. Adachi, D. Le Roy, N. Ohno, T. Yadomae, M. P. Glauser, and T. Calandra Role of Plasma, Lipopolysaccharide-Binding Protein, and CD14 in Response of Mouse Peritoneal Exudate Macrophages to Endotoxin Infect. Immun., January 1, 2001; 69(1): 378 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. E. Vreugdenhil, A. M. P. Snoek, J. W. M. Greve, and W. A. Buurman Lipopolysaccharide-Binding Protein Is Vectorially Secreted and Transported by Cultured Intestinal Epithelial Cells and Is Present in the Intestinal Mucus of Mice J. Immunol., October 15, 2000; 165(8): 4561 - 4566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Scott, C. M. Rosenberger, M. R. Gold, B. B. Finlay, and R. E. W. Hancock An {alpha}-Helical Cationic Antimicrobial Peptide Selectively Modulates Macrophage Responses to Lipopolysaccharide and Directly Alters Macrophage Gene Expression J. Immunol., September 15, 2000; 165(6): 3358 - 3365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ermert, M. Merkle, R. Mootz, F. Grimminger, W. Seeger, and L. Ermert Endotoxin priming of the cyclooxygenase-2-thromboxane axis in isolated rat lungs Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1195 - L1203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Scott, A. C. E. Vreugdenhil, W. A. Buurman, R. E. W. Hancock, and M. R. Gold Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein J. Immunol., January 15, 2000; 164(2): 549 - 553. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
